Philips and Cognizant collaborate to introduce digital health solutions to providers, researchers, and patients
08 July 2021 - 11:00PM
Philips and Cognizant collaborate to introduce digital health
solutions to providers, researchers, and patients
Alliance Pairs Cloud-Based Healthcare Platform with
Experience-Oriented Application Design to Improve Patient Care and
Clinical Trials Through Increased Provider-Patient Connectivity
AMSTERDAM, THE NETHERLANDS and TEANECK, NJ – July 8,
2021 – Royal Philips (NYSE: PHG, AEX: PHIA), a global
leader in health technology, and Cognizant (Nasdaq: CTSH), a
world-leading professional services firm, today announced a new
collaboration to develop end-to-end digital health solutions that
will enable healthcare organizations and life sciences companies to
improve patient care and accelerate clinical trials. The strategic
alliance brings together Philips HealthSuite, a cloud-based
platform and Cognizant’s digital engineering expertise to deliver
and maintain leading-edge digital health solutions at scale,
providing advanced connectivity and using big data to create
actionable insights.
Philips HealthSuite, built on Amazon Web Services, is an
integrated, modular set of standards-based capabilities that
support the development of digital health propositions. The
platform securely stores critical healthcare data and provides both
advanced data analytics and AI capabilities, while delivering
industry-leading interoperability, connectivity, and regulatory
compliance. To date, more than 100 types of medical devices have
been integrated into HealthSuite, with over 145 billion clinical
images securely archived on the cloud platform.
As part of this collaboration, Cognizant will build, deploy,
implement, and operate client-specific applications on Philips
HealthSuite. These customizable, scalable solutions integrate
advanced data analytics, helping to improve both the patient and
clinician experience by providing relevant data to the appropriate
point-of-care.
With these solutions, healthcare providers can monitor their
patients outside traditional clinical settings, and patients can
stay more informed of their own well-being. In addition, both
biopharmaceutical and medical device manufacturers can quickly gain
actionable insights through advanced analytics to make more
informed clinical development decisions and rapidly bring new
solutions to patients.
“Despite advances, patients and clinicians still face a
fragmented technology and data landscape that holds back innovative
healthcare services which improve care quality and the human
experience,” said Shez Partovi, Chief Innovation & Strategy
Officer, Royal Philips. “Philips is committed to driving the
digital transformation of healthcare. Partnering with Cognizant’s
experienced digital engineering teams will accelerate the adoption
of solutions built on Philips HealthSuite, delivering digital
solutions across the healthcare continuum in a secure and compliant
manner, and ultimately helping guide better health decisions for
patients.”
For Life Sciences companies, Philips HealthSuite’s compliant and
secure medical device connectivity, data integration and analysis
will also benefit remote patient monitoring and decentralized
clinical trials. This will enable a reduction in paperwork, help
researchers reach more diverse trial participants, and improve
connectivity between investigators and participants – with the goal
of improving the quality and speed of therapy development.
“Cognizant and Philips are each dedicated to improving people’s
lives through health technology,” said Ursula Morgenstern,
President of Global Growth Markets at Cognizant. “This new
collaboration will provide critical solutions that help manage the
growing amount of health data available, keep patients and
providers better connected, and help accelerate life-saving
therapies to market. Virtual and digital health solutions are
fundamental to improving health awareness and engagement. We are
proud to work with Philips, a world leader in healthtech, to
support the health and well-being of people everywhere.”
Learn More:
- Philips HealthSuite
- Cognizant Life Sciences
About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health
technology company focused on improving people's health and
well-being, and enabling better outcomes across the health
continuum – from healthy living and prevention, to diagnosis,
treatment and home care. Philips leverages advanced technology and
deep clinical and consumer insights to deliver integrated
solutions. Headquartered in the Netherlands, the company is a
leader in diagnostic imaging, image-guided therapy, patient
monitoring and health informatics, as well as in consumer health
and home care. Philips generated 2020 sales of EUR 17.3 billion and
employs approximately 77,000 employees with sales and services in
more than 100 countries. News about Philips can be found at
www.philips.com/newscenter.
About Cognizant
Cognizant (Nasdaq-100: CTSH) is one of the world’s leading
professional services companies, transforming clients’ business,
operating and technology models for the digital era. Our unique
industry-based, consultative approach helps clients envision, build
and run more innovative and efficient businesses. Headquartered in
the US, Cognizant is ranked 185 on the Fortune 500 and is
consistently listed among the most admired companies in the world.
Learn how Cognizant helps clients lead with digital at
www.cognizant.com or follow us @Cognizant.
For further information,
contact:
Cognizant (US)Josh Blumenthaljoshua.blumenthal@cognizant.com
Cognizant (Europe, Asia-Pac)Christina
Schneiderchristina.schneider@cognizant.com
Cognizant (India)Rashmi Vasishtrashmi.vasisht@cognizant.com
Philips Global Press OfficeMark
Grovesmark.groves@philips.com
- A digital health solution built on Philips HealthSuite
- Cognizant Philips logo lockup
Koninklijke Philips NV (EU:PHIA)
Historical Stock Chart
From Apr 2024 to May 2024
Koninklijke Philips NV (EU:PHIA)
Historical Stock Chart
From May 2023 to May 2024